Prognostic significance of the combination of biological parameters in breast cancer

Surgery Today

Volumn 33, Issue 2, 2003, Pages 151-154

  Tsutsui, Shinichi ^a   Ohno, Shinji ^b   Murakami, Shigeru ^b   Kataoka, Akemi ^b   Kinoshita, Junko ^b   Hachitanda, Yoichi ^b  

^a NATIONAL HOSPITAL ORGANIZATION BEPPU MEDICAL CENTER   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

DNA ploidy; Epidermal growth factor receptor; Estrogen receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PLOIDY; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0037288265     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950300035     Document Type: Article

References (10)

1. Noguchi M, Mizukami Y, Kinoshita K, Earashi M, Thomas M, Miyazaki I. The prognostic significance of epidermal growth factor receptor expression in breast cancer. Surg Today 1994;24:889-94.
2. Fisher B, Bauer M, Wickerham L, Redmond CK, Fisher ER. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 1983;53:1551-7.
3. Tsutsui S, Ohno S, Murakami S, Hachitanda Y, Oda S. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer. Breast Cancer Res Treat 2002;71:67-75.
4. Tsutsui S, Ohno S, Murakami S, Hachitanda Y, Oda S. Prognostic value of DNA ploidy in 653 Japanese women with node negative breast cancer. Int J Clin Oncol 2002;6:177-82.
5. Tsutsui S, Ohno S, Murakami S, Hachitanda Y, Oda S. DNA aneuploidy in relation to the combination of estrogen receptor, progesterone receptor, p53 protein and epidermal growth factor receptor in 498 breast cancer. Oncology 2002;63:48-55.
6. Tsuchiya A, Nihei M, Ando Y, Suzuki S, Kimijima I, Abe R. The relationship of estrogen receptor status to DNA ploidy in breast cancer. Surg Today 1992;22:105-9.
7. Railo M, Nordling S, von Boguslawsky K, Leivonen M, Kyllonen L, von Smitten K. Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. Br J Cancer 1993;68:579-83.
8. Jong A, van Diet PJ, Baak JPA. Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology 2000;36:306-12.
9. Yano M, Hirai K, Naito Z, Yokoyama M, Ishiwata T, Shiraki Y, et al. Expression of cathepsin B and cystatin C in human breast cancer. Surg Today 2001;31:385-9.
10. Bland KI, Konstadoulakis MM, Vezeridis MP, Wanebo HJ. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg 1995;221:706-20.